1. 269 Molecular interplay between cancer cell fatty acid metabolism and oncogenic signaling as resource for novel treatment strategies against ovarian cancer. (September 2015) Authors: Wagner, R.; Veigel, D.; Pröstling, K.; Stübiger, G.; Grusch, M.; Weghuber, J.; Singer, C.; Karlic, H.; Colomer, R.; López-Rodrýguez, M.L.; Benhamú, B.; Hegardt, F.G.; Serra, D.; Garcýa, J.; Valent, P.; Grunt, T.W. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exploiting cross-talk between lipid metabolism and oncogenic signaling for treatment of ovarian cancer. (July 2016) Authors: Wagner, R.; Stübiger, G.; Lanzerstorfer, P.; Weghuber, J.; Karteris, E.; Nowikovsky, K.; Wilfinger, N.; Colomer, R.; López-Rodríguez, M.L.; Grunt, T.W. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients. (March 2019) Authors: Rogado, J.; Sánchez-Torres, J.M.; Romero-Laorden, N.; Ballesteros, A.I.; Pacheco-Barcia, V.; Ramos-Leví, A.; Arranz, R.; Lorenzo, A.; Gullón, P.; Donnay, O.; Adrados, M.; Costas, P.; Aspa, J.; Alfranca, A.; Mondéjar, R.; Colomer, R. Journal: European journal of cancer Issue: Volume 109(2019) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗